Researchers develop a deep learning framework to accelerate ultra-low-field brain MRI, achieving faster scan times and enhanced image quality. The method shows promise in making MRI more accessible and reliable, especially in settings with limited access to high-field scanners.
John Maraganore’s RNAi biotech City Therapeutics debuts with $135M Series A
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
October 9, 2024